Postpartum Hemorrhage (PPH) Treatment Devices Market
Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023
Press Release :
It is projected that the global postpartum hemorrhage treatment devices market will witness a highly promising rate of growth in the coming years of the forecast period. Postpartum hemorrhage is extremely common type of obstetric hemorrhage. In addition to this, it is also a leading cause of maternal casualties. As per the research study published by World Health Organization, nearly a quarter of maternal casualties occur because of the postpartum hemorrhage. It is classified as a primary PPH where the loss of blood is lower than 500 ml. In secondary PPH, the blood loss is more than 500 ml. Presently, the management of third labor actively participated for avoiding PPH that is injected directly after the birth of child.
Postpartum hemorrhage can be treated with the fist level (non-surgical) techniques that involves the uptake of uterotonic drugs such as misoprostol and oxytocin. However, in case of drug absence, second string of intervention devices are adopted. Typically, these postpartum hemorrhage treatment devices include inject prefilled injection systems, uterine balloon tamponade, and non-pneumatic anti-shock garment. Since such devices are highly effective in cutting down the loss of blood and eventually stopping the flow, there is an increased demand for the same. Moreover, they also help in stabilizing the condition of the patient till the time more substantive care is offered.
One of the key driving factor for the development of the global postpartum hemorrhage treatment devices market is the increasing prevalence of pregnancy related complications such as large size of baby, inverted uterus, and multiple pregnancies among others. In addition to this, greater postpartum hemorrhage risk factors such as growing anemia cases, trauma, and uterine atony among others in pregnant women is also a key driving factor for the overall development of the global postpartum hemorrhage treatment devices market.
The escalating cases of maternal deaths have fuelled demand for advanced therapeutics and devices to ensure effective treatment for pregnancy related complications. Spurred by the factor, demand from the postpartum hemorrhage (PPH) treatment devices market is expected to increase considerably. While manufacturers of these devices have found lucrative prospects in developed nations, they are yet to establish their presence across developing and under developed countries.
According to Transparency Market Research (TMR), lack of awareness creates bottlenecks for entry of PPH treatment device manufacturers in nations across the Middle East, Asia Pacific, and sub-Saharan Africa. Nevertheless, with governments and leading organizations focusing on spreading awareness about PPH treatment, proliferation of PPH devices is expected to pace up in the forthcoming years.
TMR forecasts the global PPH treatment market to exhibit a CAGR of 4.9% between 2015 and 2021. The market stood at US$604.4 mn in 2014 and is expected to reach US$926.1 mn by the end of 2023.
Demand for Uniject Prefilled Injection Systems to Rise at Higher Pace than other Product Segments
Among the various products available, the market is currently witnessing considerably high demand for uterine balloon tamponade. It is commercially available, offers high effectiveness, and ensures ease of use. Balloon tamponade thus emerged as the dominant product segment in the market in 2014. It is expected to rise at a CAGR of 4.9% between 2015 and 2023.
However, according to TMR, demand for uniject prefilled injection systems is likely to increase at a higher pace than other products available in the market. Uniject is an auto-disable and disposable injection system. The product segment is expected to witness considerably rising demand through the forecast period due to the easy applicability of uniject prefilled injection systems, their equitable pricing, and rising participation by government organizations in promoting their use.
Besides this, TMR also projects the application of non-pneumatic anti-shock garment (NASG) to increase significantly in the near future.
Commercial Availability of Advanced Devices Confirms North America’s Lead in Global PPH Treatment Devices Market
Regionally, the global PPH treatment devices market is currently dominated by North America. The region held over 36.1% of the global market in 2014. The rising prevalence of PPH in North America, increasing awareness among patients as well as healthcare service providers, high hospital delivery rates, and commercial availability of treatment devices are the primary factors fuelling demand from the North America treatment devices market. Manufacturers of PPH treatment devices have been witnessing lucrative opportunities in countries such as the U.S., Canada, and Mexico. These countries boast sophisticated healthcare infrastructure, which aids the expansion of the PPH treatment devices market in the region.
Europe trailed North America in terms of revenue contributed to the global PPH treatment devices market in 2014. However, during the course of the forecast period, demand from Asia Pacific is expected to rise at a higher pace. The improving healthcare infrastructure will fuel demand for PPH treatment devices in countries such as India, China, Philippines, and Taiwan. Furthermore, programs initiated by governments to prevent maternal deaths will also boost sales opportunities for manufacturers across these countries.
Some of the key players in the global postpartum hemorrhage treatment devices market are Bactiguard, Cook Medical, C.R. Bard, Utah Medical Products, Teleflex Incorporated, and Program for Appropriate Technology in Health (PATH).
Global Postpartum Hemorrhage Treatment Devices Market - Overview:
Advanced therapeutics in maternal health is the need of the hour, particularly because of the high number of maternal deaths that is being witnessed worldwide. This development in therapy and drugs is also making inroads into the postpartum hemorrhage treatment devices market, driving the market onto a high growth trajectory.
It is worth noting here that for market players, while a large share is generated in the developed world, over the forecast period, new opportunities will arise in the developing regions as well, fueling growth in the global postpartum hemorrhage treatment devices market. Moreover, it paves the perfect foundation for players to make the most of these opportunities in the coming few years.
Thus, as per Transparency Market Research, a steady growth trajectory will be noted between 2015 and 2023, generating a worthwhile market revenue of this period. As per statistics, a CAGR of 4.9% will be charted in this period, raking the market worth up to USD 926.1 million.
It is worth noting here that certain factors are underlying the growth of global postpartum hemorrhage treatment devices market over the period stated above. These are spelled out below:
- North America will lead the global postpartum hemorrhage treatment devices market owing to availability of advanced devices commercially. The region will account for a massive market share over the period and will ride the wave of increasing awareness among women and high rate of hospital deliveries
- As women earn and gain self-sufficiency in terms of money, demand for better healthcare measures witness an upward rise. The increase in spending capacity and rising awareness is leading to increase in demand for better postpartum hemorrhage treatment devices over the stated period, helping the market chart a steep curve in the upward direction
Postpartum hemorrhage (PPH) can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery. If this amount of blood loss occurs within 24 hours of delivery, it is categorized as early or primary PPH. If such blood loss occurs after 24 hours of delivery, it is categorized as late or secondary PPH. This study provides market analysis for various medical devices that are used for the treatment of postpartum hemorrhage. The stakeholders of this market report comprise established medical device manufacturers, distributors, and new players who wish to enter the global postpartum hemorrhage treatment devices market.
This study provides a comprehensive analysis of the global postpartum hemorrhage treatment devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the PPH treatment devices market in terms of current and future market size along with growth rate.
The market overview section provides thorough information on the trends in the usage of medical devices used for the treatment of PPH, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this report to provide analysis about the level of competition within the postpartum hemorrhage treatment devices market. Furthermore, a section analyzing the regulatory framework and major events provides a bird’s-eye view on the major and upcoming events occurring in the global postpartum hemorrhage treatment devices market that could impact growth. Competitive intelligence tools such as heat map analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall scenario in the market at global level. Heat map analysis thus provided in this study is in context with major product manufacturers and distributors operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the PPH treatment devices market.
The global postpartum hemorrhage treatment devices market has been segmented based on various products used across various geographies. The postpartum hemorrhage treatment devices market has been categorized into major products used for providing therapeutic treatment measures such as non-pneumatic anti-shock garment (NASG), the Uniject prefilled injection system, and uterine balloon tamponade. The uterine balloon tamponade segment has been further segmented into Foley catheters, condom catheters, and others (e.g. Bakri, Rusch, etc.). The market size for the period from 2013 to 2023 has been provided for each of the product categories mentioned above in terms of USD million. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 has also been provided.
Geographically, the PPH treatment devices market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, and Rest of Asia Pacific. The market revenue of PPH treatment devices for each geographical region for 2013 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD million, has been explained in the geography section of the report.
This market study concludes with profiles of key players in the global postpartum hemorrhage treatment devices market. The report summarizes the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Key organizations profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG.
The global postpartum hemorrhage treatment devices market is segmented into the following categories:
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products
- Non-pneumatic Anti-shock Garment (NASG)
- Uniject Prefilled Injection System
- Uterine Balloon Tamponade
- Foley Catheters
- Condom Catheters
Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Middle East & North Africa (MENA)
- Rest of the World